# Novartis AG: Form 6-K, filed Oct 24, 2022

- Company: [Novartis AG](/companies/nvs.md) (CIK 1114448)
- Form: 6-K
- Filed: 2022-10-24
- Accepted by EDGAR: Oct 24, 2022, 06:05 ET
- Period: 2022-10-24
- Accession: 0001171843-22-006695
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1114448/000117184322006695/f6k_102422.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1114448/000117184322006695/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1114448/000117184322006695/f6k_102422.htm

Filed Oct 24, 2022.
Source: SEC EDGAR, the filing index for accession 0001171843-22-006695. Last ingested by Listed: Nov 13, 2026, 16:23 ET. No prices; not investment advice.
